Advertisement

Screening for Complement Deficiency

  • Ann Orren
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 150)

Abstract

Complement (C) deficiencies are not common and laboratory screening for clinical reasons generally involves examining relatively few samples. Nevertheless, because of the range of tests, complete testing may mean carrying out many different assays. In contrast, the determination of the prevalence of genetic complement deficiencies in populations requires a very few specific methods that are suitable for dealing with a large number of samples.

Keywords

Alternative Pathway Classical Pathway Normal Human Serum Immunochemical Assay Complement Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Schifferli J. A., Ng Y. C., and Peters D. K. (1986) The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med. 315,488–495.PubMedCrossRefGoogle Scholar
  2. 2.
    Morgan B. P. and Walport M. J. (1991) Complement deficiency and disease. Immunol. Today 12, 301–306.PubMedCrossRefGoogle Scholar
  3. 3.
    Figueroa J. E. and Densen P. (1991) Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4, 359–395.PubMedGoogle Scholar
  4. 4.
    Botto M., Fong K. Y., So A. K., Rudge A., and Walport M. J. (1990) Molecular basis of hereditary C3 deficiency. J. Clin. Invest. 86, 1158–1163.PubMedCrossRefGoogle Scholar
  5. 5.
    Thompson R. A. and Winterborn M. H. (1981) Hypocomplementaemia due to agenetic deficiency of beta 1H globulin. Clin. Exp. Immunol. 46, 110–119.PubMedGoogle Scholar
  6. 6.
    Vyse T. J., Späth P. J., Davies K. A., Morley B. J., Philippe P., Athanassiou P., et al. (1994) Hereditary complement factor I deficiency. Q. J. Med. 87, 385–401.Google Scholar
  7. 7.
    Skattum L., Martensson U., and Sjöholm A. G. (1997) Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies. J. Intern. Med. 242, 455–464.PubMedCrossRefGoogle Scholar
  8. 8.
    Levy Y., George J., Yona E., and Shoenfeld Y. (1998) Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon. Immunol. Res. 18, 55–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Ross S. C. and Densen P. (1984) Complement deficiency status and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63,243–273.Google Scholar
  10. 10.
    Würzner R., Orren A., and Lachmann P. J. (1992). Inherited deficiencies of the terminal components of human complement. Immunodef. Rev. 3, 123–147.PubMedGoogle Scholar
  11. 11.
    Sjöholm A. G., Braconier J.-H., and Söderström C. (1982) Properdin deficiency in a family with fulminant meningococcal infections. Clin. Exp. Immunol. 50, 291–297.PubMedGoogle Scholar
  12. 12.
    Fijen C. A., Kuijper E. J., Hannema A. J., Sjöholm A. G., and van-Putten J. P. (1989) Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet ii (8663), 585–588.CrossRefGoogle Scholar
  13. 13.
    Orren A., Caugant D. A., Fijen C. A. P., Dankert J., Van Schalkwyk E. J., Poolman J. T., and Coetzee G. J. (1994) Characterization of strains of Neisseria meningitidis recovered from complement-normal and complement-deficient patients in the Cape, South Africa. J. Clin. Microbiol. 32, 2185–2191.PubMedGoogle Scholar
  14. 14.
    Super M., Thiel S., Lu J., Levinsky R. J., and Turner M. W. (1989) Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet ii (8674), 1236–1239.CrossRefGoogle Scholar
  15. 15.
    Kishimoto T. K., Hollander N., Roberts T. M., Anderson D. C., and Springer T. A. (1987) Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell 50, 193–202.PubMedCrossRefGoogle Scholar
  16. 16.
    Rosse W. F. (1997) Paroxysmal Nocturnal Haemoglobinuria (PNH) as a molecular disease. Medicine (Baltimore) 76, 63–93.CrossRefGoogle Scholar
  17. 17.
    Brandtzaeg P., Mollnes T. E., and Kierulf P. (1989) Complement activation and Endotoxin levels in Meningococcal Disease. J. Infect. Dis. 160, 58–65.PubMedGoogle Scholar
  18. 18.
    Jeffreys A. J. (1979) DNA sequence variants in the Gγ-, Aγ-, Δ-and β-globin genes of man. Cell 18, 1–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Harrison R. A. and Lachmann P. J. (1986) Complement technology, in Handbook of Experimental Immunology, vol. 1 (Weir D. M., ed.), Blackwell Scientific, Oxford, pp. 39.1–39.49.Google Scholar
  20. 20.
    Tedesco F., Densen P., Villa M. A., Petersen B. H., and Sirchia G. (1983) Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal molecules. J. Clin. Invest. 71, 183–191.PubMedCrossRefGoogle Scholar
  21. 21.
    Morgan B. P., Daw R. A., Siddle K., Luzio J. P., and Campbell A. K. (1983) Immunoaffinity purification of human complement C9 using monoclonal antibodies. J. Immunol. Methods 64, 269–281.PubMedCrossRefGoogle Scholar
  22. 22.
    Egan L., Orren A., Doherty J., Würzner R., and McCarthy C. F. (1994) Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations in an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping. Epidemiol. Infect. 113, 275–281.PubMedCrossRefGoogle Scholar
  23. 23.
    Orren A., Würzner R., Potter P. C., Fernie B. A., Coetzee S., Morgan B. P., and Lachmann P. J. (1991) Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiency. Immunology 75, 10–16.Google Scholar
  24. 24.
    Lachmann P. J., Pangburn M. K., and Oldroyd R. G. (1982) Breakdown of C3 after complement activation: identification of a new fragment, C3g, using monoclonal antibodies. J. Exp. Med. 156, 205–216.PubMedCrossRefGoogle Scholar
  25. 25.
    Teisner B., Brandslund I., Folkersen J., Rasmussen J. M., Poulsen L. O., and Svehag S.-E. (1984) Factor I deficiency and C3 nephritic factor: Immunochemical findings and association with Neisseria meningitidis infection in two patients. Scand. J. Immunol. 20, 291–297.PubMedCrossRefGoogle Scholar
  26. 26.
    Densen P., Weiler J. M., Griffiss J. M., and Hoffmann L. G. (1987) Familial properdin deficiency and fatal meningococcaemia. Correction of the bactericidal defect by vaccination. N. Engl. J. Med. 316, 922–926.PubMedCrossRefGoogle Scholar
  27. 27.
    Sjöholm A. G., Kuijper E. J., Tijssen C. C., Jansz A., Bol P., Spanjaard L., and Zanen H. C. (1988) Dysfunctional properdin in a Dutch family with meningococcal disease. N. Eng. J. Med. 319, 33–37.CrossRefGoogle Scholar
  28. 28.
    Würzner R., Witzel-Schlömp K., Tokunaga K., Fernie B. A., Hobart M. J., and Orren A. (1998) Reference Typing Report for Complement Components C6, C7 and C9, including mutations leading to deficiencies. Exp. Clin. Immunogenet., 15, 268–285.PubMedCrossRefGoogle Scholar
  29. 29.
    Hobart M. J., Fernie B. A., Fijen K. A. P. M., and Orren A. (1998) The molecular bases of C6 deficiency in the Western Cape, South Africa. Hum. Genet., 103, 506–512.PubMedCrossRefGoogle Scholar
  30. 30.
    Fowke K. R., Plummer F. A., and Simonsen J. N. (1995) Genetic analysis of human DNA recovered from minute amounts of serum or plasma. J. Immunol. Meth., 180, 45–51.CrossRefGoogle Scholar
  31. 31.
    Fernie B. A., Finlay A., Price D., Chan E., Orren A., Joysey V. C., et al. (1996) Complement C6 and C7 DNA polymorphisms analysed by PCR in seven ethnic groups and characterisation of the C6 MspI RFLP. Exp. Clin. Immunogenet. 13, 92–103.PubMedGoogle Scholar
  32. 32.
    Fukumori Y., Yoshimura K., Ohnoki S., Yamaguchi H., Akagaki Y. and Inai S. (1989) A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan. Int. Immunol. 1, 85–89.PubMedCrossRefGoogle Scholar
  33. 33.
    Hobart M. J., Fernie B. A., Würzner R., Oldroyd R. G., Harrison R. A., Joysey V., and Lachmann P. J. (1997) Difficulties in the ascertainment of C9 deficiency: lessons to be drawn from a compound heterozygote C9-deficient subject. Clin. Exp. Immunol. 108, 500–506.PubMedCrossRefGoogle Scholar
  34. 34.
    Stolfi R. L. (1968) Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in guinea pig complement system. J. Immunol. 100, 46–54.PubMedGoogle Scholar
  35. 35.
    Witzel-Schlömp K., Hobart M. J., Fernie B. A., Orren A., Würzner R., Rittner C., et al. (1998) Heterogeneity in the genetic basis of human complement C9 deficiency. Immunogenetics 34, 144–147.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Ann Orren
    • 1
  1. 1.Department of MicrobiologyNational University of Ireland GalwayGalway

Personalised recommendations